Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes

We report the most extensive analysis to date of VP1 and HLA-I in pancreases from donors with preclinical and diagnosed type 1 diabetes. We find an association of VP1 with residual beta cells after diagnosis and demonstrate VP1 positivity during the autoantibody-positive preclinical stage. For the first time, we show that VP1 positivity and HLA-I hyperexpression in islet cells are both present during the preclinical stage. While the study of tissues does not allow us to demonstrate causality, our data support the hypothesis that enterovirus infections may occur throughout the natural history of type 1 diabetes and may be one of multiple mechanisms driving islet cell HLA-I hyperexpression.

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2025-03-16
DOI
https://doi.org/10.1007/s00125-025-06384-9
Citations
12
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
21.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes

Thomas Worthington, Sisko Tauriainen, Jutta E. Laiho, Heikki Hyöty et al.
12 citations
Diabetologia
Diabetes and associated disorders
21.81
article

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes

Thomas Worthington, Sisko Tauriainen, Jutta E. Laiho, Heikki Hyöty, Christine S. Flaxman, Alberto Pugliese, Paola S. Apaolaza, Noel G. Morgan, Matthias von Herrath, Irina Kusmartseva, Maarit Oikarinen, Pouria Akhbari, Sarah J. Richardson, Mark A. Atkinson, Teresa Rodríguez-Calvo, John S. Kaddis, Martha Campbell‐Thompson
article en
12 citations

Abstract

We report the most extensive analysis to date of VP1 and HLA-I in pancreases from donors with preclinical and diagnosed type 1 diabetes. We find an association of VP1 with residual beta cells after diagnosis and demonstrate VP1 positivity during the autoantibody-positive preclinical stage. For the first time, we show that VP1 positivity and HLA-I hyperexpression in islet cells are both present during the preclinical stage. While the study of tissues does not allow us to demonstrate causality, our data support the hypothesis that enterovirus infections may occur throughout the natural history of type 1 diabetes and may be one of multiple mechanisms driving islet cell HLA-I hyperexpression.

DiabetologiaVol. 68(6)
University of Miami (US), University of Turku (FI), Tampere University (FI), Novo Nordisk (Denmark) (DK), University of Exeter (GB), Helmholtz Zentrum München (DE), University of Florida (US), City of Hope (US), Tampere University Hospital (FI), Tampere University (FI), Fimlab (Finland) (FI), Beckman Research Institute
Juvenile Diabetes Research Foundation International, Leona M. and Harry B. Helmsley Charitable Trust, Human Islet Research Network, National Institute for Health and Care Research, University of Exeter, European Commission, European Foundation for the Study of Diabetes, Suomen Kulttuurirahasto, Diabetestutkimussäätiö, Medical Research Council, Faculty of Medicine and Health, University of Sydney, National Institute of Diabetes and Digestive and Kidney Diseases
Good health and well-being
Openalex Percentile: Top 0%
Diabetes and associated disorders
21.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.